CA2887206A1 - Methods and systems for microfluidics imaging and analysis - Google Patents

Info

Publication number

CA2887206A1

CA2887206A1 CA2887206A CA2887206A CA2887206A1 CA 2887206 A1 CA2887206 A1 CA 2887206A1 CA 2887206 A CA2887206 A CA 2887206A CA 2887206 A CA2887206 A CA 2887206A CA 2887206 A1 CA2887206 A1 CA 2887206A1

Authority

CA

Canada

Prior art keywords

sample

data

image

nucleic acid

reaction

Prior art date

2012-10-05

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 200
• 238000004458 analytical method Methods 0.000 title claims description 68
• 238000003384 imaging method Methods 0.000 title description 65
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 31
• 201000010099 disease Diseases 0.000 claims abstract description 28
• 238000006243 chemical reaction Methods 0.000 claims description 184
• 150000007523 nucleic acids Chemical class 0.000 claims description 141
• 238000003199 nucleic acid amplification method Methods 0.000 claims description 133
• 230000003321 amplification Effects 0.000 claims description 130
• 238000003556 assay Methods 0.000 claims description 118
• 102000039446 nucleic acids Human genes 0.000 claims description 111
• 108020004707 nucleic acids Proteins 0.000 claims description 111
• 108090000623 proteins and genes Proteins 0.000 claims description 53
• 238000011002 quantification Methods 0.000 claims description 52
• 238000001514 detection method Methods 0.000 claims description 47
• 238000012545 processing Methods 0.000 claims description 43
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 36
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 34
• 230000008569 process Effects 0.000 claims description 32
• 102000004169 proteins and genes Human genes 0.000 claims description 27
• 238000005259 measurement Methods 0.000 claims description 25
• 241000700605 Viruses Species 0.000 claims description 21
• 230000008859 change Effects 0.000 claims description 19
• 239000007850 fluorescent dye Substances 0.000 claims description 19
• 230000035484 reaction time Effects 0.000 claims description 18
• 238000004422 calculation algorithm Methods 0.000 claims description 14
• 241000894006 Bacteria Species 0.000 claims description 12
• 230000005540 biological transmission Effects 0.000 claims description 12
• 230000003287 optical effect Effects 0.000 claims description 12
• DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical group O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 claims description 11
• 238000007405 data analysis Methods 0.000 claims description 11
• 230000035772 mutation Effects 0.000 claims description 11
• 229960002378 oftasceine Drugs 0.000 claims description 11
• 238000007619 statistical method Methods 0.000 claims description 11
• 208000026350 Inborn Genetic disease Diseases 0.000 claims description 8
• 208000016361 genetic disease Diseases 0.000 claims description 8
• 230000003612 virological effect Effects 0.000 claims description 8
• 238000003745 diagnosis Methods 0.000 claims description 7
• 238000001914 filtration Methods 0.000 claims description 7
• 230000001404 mediated effect Effects 0.000 claims description 7
• 241000894007 species Species 0.000 claims description 7
• 238000003705 background correction Methods 0.000 claims description 6
• 229910052724 xenon Inorganic materials 0.000 claims description 6
• FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 claims description 6
• 230000000903 blocking effect Effects 0.000 claims description 5
• 238000010295 mobile communication Methods 0.000 claims description 5
• 238000001506 fluorescence spectroscopy Methods 0.000 claims description 4
• 230000002045 lasting effect Effects 0.000 claims description 4
• 241001465754 Metazoa Species 0.000 claims description 3
• 238000002211 ultraviolet spectrum Methods 0.000 claims description 3
• 208000035143 Bacterial infection Diseases 0.000 claims description 2
• 208000036142 Viral infection Diseases 0.000 claims description 2
• 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
• 238000013480 data collection Methods 0.000 claims description 2
• 230000009385 viral infection Effects 0.000 claims description 2
• 238000001429 visible spectrum Methods 0.000 claims description 2
• 239000000523 sample Substances 0.000 description 215
• 210000004027 cell Anatomy 0.000 description 90
• 239000013615 primer Substances 0.000 description 76
• 108020004414 DNA Proteins 0.000 description 67
• 238000003752 polymerase chain reaction Methods 0.000 description 55
• 239000000243 solution Substances 0.000 description 40
• 239000011521 glass Substances 0.000 description 39
• 239000012491 analyte Substances 0.000 description 35
• 241000725303 Human immunodeficiency virus Species 0.000 description 32
• 239000000203 mixture Substances 0.000 description 32
• 239000011324 bead Substances 0.000 description 31
• 238000007397 LAMP assay Methods 0.000 description 28
• 239000000126 substance Substances 0.000 description 27
• 239000003153 chemical reaction reagent Substances 0.000 description 26
• 108091034117 Oligonucleotide Proteins 0.000 description 25
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
• 108020000999 Viral RNA Proteins 0.000 description 24
• 238000002474 experimental method Methods 0.000 description 23
• 239000000463 material Substances 0.000 description 21
• 102100034343 Integrase Human genes 0.000 description 20
• 238000003860 storage Methods 0.000 description 20
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
• 230000009471 action Effects 0.000 description 19
• 108091023037 Aptamer Proteins 0.000 description 17
• 238000004891 communication Methods 0.000 description 17
• 235000018102 proteins Nutrition 0.000 description 17
• 102000053602 DNA Human genes 0.000 description 16
• 102000004190 Enzymes Human genes 0.000 description 16
• 108090000790 Enzymes Proteins 0.000 description 16
• 238000010804 cDNA synthesis Methods 0.000 description 16
• 229940088598 enzyme Drugs 0.000 description 16
• 239000000047 product Substances 0.000 description 16
• 108020004635 Complementary DNA Proteins 0.000 description 15
• 239000002299 complementary DNA Substances 0.000 description 15
• 239000002245 particle Substances 0.000 description 15
• 239000012071 phase Substances 0.000 description 15
• 238000005530 etching Methods 0.000 description 14
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 13
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 13
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 13
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 12
• 238000004364 calculation method Methods 0.000 description 12
• 230000006870 function Effects 0.000 description 12
• 238000011068 loading method Methods 0.000 description 12
• 238000012986 modification Methods 0.000 description 12
• 230000004048 modification Effects 0.000 description 12
• 239000002131 composite material Substances 0.000 description 11
• 239000000975 dye Substances 0.000 description 11
• 230000005284 excitation Effects 0.000 description 11
• -1 i.e. Chemical group 0.000 description 11
• 239000002773 nucleotide Substances 0.000 description 11
• 125000003729 nucleotide group Chemical group 0.000 description 11
• 229920000642 polymer Polymers 0.000 description 11
• 101710203526 Integrase Proteins 0.000 description 10
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 10
• 230000000670 limiting effect Effects 0.000 description 10
• 239000004033 plastic Substances 0.000 description 10
• 229920003023 plastic Polymers 0.000 description 10
• 238000010839 reverse transcription Methods 0.000 description 10
• VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 9
• 241000196324 Embryophyta Species 0.000 description 9
• 239000000370 acceptor Substances 0.000 description 9
• 229910052804 chromium Inorganic materials 0.000 description 9
• 239000011651 chromium Substances 0.000 description 9
• 238000002866 fluorescence resonance energy transfer Methods 0.000 description 9
• 238000003753 real-time PCR Methods 0.000 description 9
• 239000000758 substrate Substances 0.000 description 9
• 238000011282 treatment Methods 0.000 description 9
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
• 238000012408 PCR amplification Methods 0.000 description 8
• 230000027455 binding Effects 0.000 description 8
• 239000000090 biomarker Substances 0.000 description 8
• 238000013461 design Methods 0.000 description 8
• 229910001873 dinitrogen Inorganic materials 0.000 description 8
• 230000000694 effects Effects 0.000 description 8
• 230000035945 sensitivity Effects 0.000 description 8
• BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 8
• 230000004544 DNA amplification Effects 0.000 description 7
• 210000004369 blood Anatomy 0.000 description 7
• 239000008280 blood Substances 0.000 description 7
• 239000000872 buffer Substances 0.000 description 7
• 238000006073 displacement reaction Methods 0.000 description 7
• 239000011159 matrix material Substances 0.000 description 7
• 229920002120 photoresistant polymer Polymers 0.000 description 7
• 210000002381 plasma Anatomy 0.000 description 7
• 238000002444 silanisation Methods 0.000 description 7
• 238000012360 testing method Methods 0.000 description 7
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
• 239000004642 Polyimide Substances 0.000 description 6
• 238000000137 annealing Methods 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 230000009089 cytolysis Effects 0.000 description 6
• 238000007847 digital PCR Methods 0.000 description 6
• 239000004205 dimethyl polysiloxane Substances 0.000 description 6
• 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
• 238000009826 distribution Methods 0.000 description 6
• 238000005516 engineering process Methods 0.000 description 6
• 238000010191 image analysis Methods 0.000 description 6
• 239000002609 medium Substances 0.000 description 6
• 239000003921 oil Substances 0.000 description 6
• 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
• 229920001721 polyimide Polymers 0.000 description 6
• 238000003757 reverse transcription PCR Methods 0.000 description 6
• 239000002689 soil Substances 0.000 description 6
• 230000006820 DNA synthesis Effects 0.000 description 5
• 208000002537 Neuronal Ceroid-Lipofuscinoses Diseases 0.000 description 5
• 102000018120 Recombinases Human genes 0.000 description 5
• 108010091086 Recombinases Proteins 0.000 description 5
• 230000008901 benefit Effects 0.000 description 5
• 210000001124 body fluid Anatomy 0.000 description 5
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
• 230000000295 complement effect Effects 0.000 description 5
• 238000012937 correction Methods 0.000 description 5
• 239000012530 fluid Substances 0.000 description 5
• 239000002090 nanochannel Substances 0.000 description 5
• 238000000746 purification Methods 0.000 description 5
• 239000013049 sediment Substances 0.000 description 5
• 238000000926 separation method Methods 0.000 description 5
• 210000001519 tissue Anatomy 0.000 description 5
• 238000013518 transcription Methods 0.000 description 5
• 230000035897 transcription Effects 0.000 description 5
• 108091093088 Amplicon Proteins 0.000 description 4
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
• 206010011878 Deafness Diseases 0.000 description 4
• 241000588724 Escherichia coli Species 0.000 description 4
• 241000233866 Fungi Species 0.000 description 4
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
• 108060004795 Methyltransferase Proteins 0.000 description 4
• 241000244206 Nematoda Species 0.000 description 4
• 229910019142 PO4 Inorganic materials 0.000 description 4
• 108091028664 Ribonucleotide Proteins 0.000 description 4
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
• 238000013459 approach Methods 0.000 description 4
• 238000001574 biopsy Methods 0.000 description 4
• 239000013522 chelant Substances 0.000 description 4
• 239000011248 coating agent Substances 0.000 description 4
• 238000000576 coating method Methods 0.000 description 4
• 230000007812 deficiency Effects 0.000 description 4
• 238000004925 denaturation Methods 0.000 description 4
• 230000036425 denaturation Effects 0.000 description 4
• 239000005547 deoxyribonucleotide Substances 0.000 description 4
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 4
• 239000012634 fragment Substances 0.000 description 4
• 208000016354 hearing loss disease Diseases 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• 230000000977 initiatory effect Effects 0.000 description 4
• 239000011777 magnesium Substances 0.000 description 4
• 230000005291 magnetic effect Effects 0.000 description 4
• 239000012528 membrane Substances 0.000 description 4
• 239000000178 monomer Substances 0.000 description 4
• 201000008051 neuronal ceroid lipofuscinosis Diseases 0.000 description 4
• CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 4
• 230000001717 pathogenic effect Effects 0.000 description 4
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
• 239000010452 phosphate Substances 0.000 description 4
• 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 4
• 239000012429 reaction media Substances 0.000 description 4
• 108091008146 restriction endonucleases Proteins 0.000 description 4
• 239000002336 ribonucleotide Substances 0.000 description 4
• 125000002652 ribonucleotide group Chemical group 0.000 description 4
• 239000005361 soda-lime glass Substances 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• 210000002700 urine Anatomy 0.000 description 4
• 241000252506 Characiformes Species 0.000 description 3
• 241000206602 Eukaryota Species 0.000 description 3
• 206010020608 Hypercoagulation Diseases 0.000 description 3
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
• 240000007594 Oryza sativa Species 0.000 description 3
• 235000007164 Oryza sativa Nutrition 0.000 description 3
• 102000006382 Ribonucleases Human genes 0.000 description 3
• 108010083644 Ribonucleases Proteins 0.000 description 3
• 108020004682 Single-Stranded DNA Proteins 0.000 description 3
• 241000191967 Staphylococcus aureus Species 0.000 description 3
• 208000004006 Tick-borne encephalitis Diseases 0.000 description 3
• 241000209140 Triticum Species 0.000 description 3
• 235000021307 Triticum Nutrition 0.000 description 3
• 239000002253 acid Substances 0.000 description 3
• 239000003570 air Substances 0.000 description 3
• 230000000692 anti-sense effect Effects 0.000 description 3
• 238000011225 antiretroviral therapy Methods 0.000 description 3
• 239000013592 cell lysate Substances 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 239000003795 chemical substances by application Substances 0.000 description 3
• 239000003086 colorant Substances 0.000 description 3
• 239000012895 dilution Substances 0.000 description 3
• 238000010790 dilution Methods 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 239000003814 drug Substances 0.000 description 3
• 238000010828 elution Methods 0.000 description 3
• 238000011049 filling Methods 0.000 description 3
• 239000000499 gel Substances 0.000 description 3
• 231100000888 hearing loss Toxicity 0.000 description 3
• 230000010370 hearing loss Effects 0.000 description 3
• 238000009396 hybridization Methods 0.000 description 3
• 238000005286 illumination Methods 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 238000007403 mPCR Methods 0.000 description 3
• 229910052749 magnesium Inorganic materials 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 229910052751 metal Inorganic materials 0.000 description 3
• 239000002184 metal Substances 0.000 description 3
• 230000000813 microbial effect Effects 0.000 description 3
• 239000013580 millipore water Substances 0.000 description 3
• 239000002480 mineral oil Substances 0.000 description 3
• 235000010446 mineral oil Nutrition 0.000 description 3
• 201000006790 nonsyndromic deafness Diseases 0.000 description 3
• 239000004417 polycarbonate Substances 0.000 description 3
• 108090000765 processed proteins & peptides Proteins 0.000 description 3
• 238000002331 protein detection Methods 0.000 description 3
• 238000012340 reverse transcriptase PCR Methods 0.000 description 3
• 108020004418 ribosomal RNA Proteins 0.000 description 3
• 235000009566 rice Nutrition 0.000 description 3
• 238000001228 spectrum Methods 0.000 description 3
• 201000005665 thrombophilia Diseases 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical group OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 208000003829 American Hemorrhagic Fever Diseases 0.000 description 2
• 241000203069 Archaea Species 0.000 description 2
• 238000012935 Averaging Methods 0.000 description 2
• 241000722910 Burkholderia mallei Species 0.000 description 2
• 241001136175 Burkholderia pseudomallei Species 0.000 description 2
• 241000222122 Candida albicans Species 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• 241000193155 Clostridium botulinum Species 0.000 description 2
• 241000223205 Coccidioides immitis Species 0.000 description 2
• 241001522757 Coccidioides posadasii Species 0.000 description 2
• 102100027591 Copper-transporting ATPase 2 Human genes 0.000 description 2
• 208000009283 Craniosynostoses Diseases 0.000 description 2
• 206010049889 Craniosynostosis Diseases 0.000 description 2
• 239000003155 DNA primer Substances 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 241000588722 Escherichia Species 0.000 description 2
• 229910052693 Europium Inorganic materials 0.000 description 2
• 206010018464 Glycogen storage disease type I Diseases 0.000 description 2
• 241000893570 Hendra henipavirus Species 0.000 description 2
• 206010020365 Homocystinuria Diseases 0.000 description 2
• 208000008852 Hyperoxaluria Diseases 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
• 208000030162 Maple syrup disease Diseases 0.000 description 2
• 208000002678 Mucopolysaccharidoses Diseases 0.000 description 2
• 208000021642 Muscular disease Diseases 0.000 description 2
• 201000009623 Myopathy Diseases 0.000 description 2
• 206010028980 Neoplasm Diseases 0.000 description 2
• 208000014060 Niemann-Pick disease Diseases 0.000 description 2
• 101150089972 Nlp gene Proteins 0.000 description 2
• 206010033128 Ovarian cancer Diseases 0.000 description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 description 2
• 239000004696 Poly ether ether ketone Substances 0.000 description 2
• 238000011529 RT qPCR Methods 0.000 description 2
• 108091006629 SLC13A2 Proteins 0.000 description 2
• 241000736032 Sabia <angiosperm> Species 0.000 description 2
• 244000061456 Solanum tuberosum Species 0.000 description 2
• 235000002595 Solanum tuberosum Nutrition 0.000 description 2
• 102100022563 Tubulin polymerization-promoting protein Human genes 0.000 description 2
• 240000008042 Zea mays Species 0.000 description 2
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
• 238000007792 addition Methods 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 239000000853 adhesive Substances 0.000 description 2
• 230000001070 adhesive effect Effects 0.000 description 2
• 239000000443 aerosol Substances 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• 210000004381 amniotic fluid Anatomy 0.000 description 2
• 238000012197 amplification kit Methods 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 239000012148 binding buffer Substances 0.000 description 2
• AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
• 239000000920 calcium hydroxide Substances 0.000 description 2
• 235000011116 calcium hydroxide Nutrition 0.000 description 2
• 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• OFZCIYFFPZCNJE-UHFFFAOYSA-N carisoprodol Chemical compound NC(=O)OCC(C)(CCC)COC(=O)NC(C)C OFZCIYFFPZCNJE-UHFFFAOYSA-N 0.000 description 2
• 238000001444 catalytic combustion detection Methods 0.000 description 2
• 230000006037 cell lysis Effects 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
• 210000002939 cerumen Anatomy 0.000 description 2
• 235000012000 cholesterol Nutrition 0.000 description 2
• 238000012790 confirmation Methods 0.000 description 2
• 229920001577 copolymer Polymers 0.000 description 2
• 230000001351 cycling effect Effects 0.000 description 2
• 231100000895 deafness Toxicity 0.000 description 2
• 230000007547 defect Effects 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 239000005549 deoxyribonucleoside Substances 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 229910003460 diamond Inorganic materials 0.000 description 2
• 239000010432 diamond Substances 0.000 description 2
• 230000005611 electricity Effects 0.000 description 2
• 238000003487 electrochemical reaction Methods 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
• 229960005542 ethidium bromide Drugs 0.000 description 2
• OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical group [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 210000003608 fece Anatomy 0.000 description 2
• 239000000835 fiber Substances 0.000 description 2
• 238000002073 fluorescence micrograph Methods 0.000 description 2
• 238000000799 fluorescence microscopy Methods 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 239000013505 freshwater Substances 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 150000004676 glycans Chemical class 0.000 description 2
• 208000007345 glycogen storage disease Diseases 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 201000005706 hypokalemic periodic paralysis Diseases 0.000 description 2
• 238000003018 immunoassay Methods 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 238000009830 intercalation Methods 0.000 description 2
• 229910052742 iron Inorganic materials 0.000 description 2
• 238000011901 isothermal amplification Methods 0.000 description 2
• 238000012933 kinetic analysis Methods 0.000 description 2
• 238000002032 lab-on-a-chip Methods 0.000 description 2
• 229910052748 manganese Inorganic materials 0.000 description 2
• 239000011572 manganese Substances 0.000 description 2
• 208000024393 maple syrup urine disease Diseases 0.000 description 2
• 238000001000 micrograph Methods 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 238000000465 moulding Methods 0.000 description 2
• 206010028093 mucopolysaccharidosis Diseases 0.000 description 2
• 239000013642 negative control Substances 0.000 description 2
• 238000007857 nested PCR Methods 0.000 description 2
• 230000007935 neutral effect Effects 0.000 description 2
• 238000001668 nucleic acid synthesis Methods 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• 230000005298 paramagnetic effect Effects 0.000 description 2
• 239000013610 patient sample Substances 0.000 description 2
• RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 2
• 229920000515 polycarbonate Polymers 0.000 description 2
• 229920002530 polyetherether ketone Polymers 0.000 description 2
• 229920001282 polysaccharide Polymers 0.000 description 2
• 239000005017 polysaccharide Substances 0.000 description 2
• 210000004909 pre-ejaculatory fluid Anatomy 0.000 description 2
• 102000004196 processed proteins & peptides Human genes 0.000 description 2
• 238000003908 quality control method Methods 0.000 description 2
• 239000011541 reaction mixture Substances 0.000 description 2
• 238000005057 refrigeration Methods 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 238000002165 resonance energy transfer Methods 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 239000011435 rock Substances 0.000 description 2
• 210000003296 saliva Anatomy 0.000 description 2
• 238000005070 sampling Methods 0.000 description 2
• 229910052710 silicon Inorganic materials 0.000 description 2
• 239000010703 silicon Substances 0.000 description 2
• 239000000377 silicon dioxide Substances 0.000 description 2
• 235000002639 sodium chloride Nutrition 0.000 description 2
• 238000000638 solvent extraction Methods 0.000 description 2
• 239000006228 supernatant Substances 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 210000004243 sweat Anatomy 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 2
• 230000007704 transition Effects 0.000 description 2
• 239000005052 trichlorosilane Substances 0.000 description 2
• 239000001226 triphosphate Substances 0.000 description 2
• 235000011178 triphosphate Nutrition 0.000 description 2
• 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 2
• 230000000007 visual effect Effects 0.000 description 2
• 238000005406 washing Methods 0.000 description 2
• 229910000667 (NH4)2Ce(NO3)6 Inorganic materials 0.000 description 1
• DILISPNYIVRDBP-UHFFFAOYSA-N 2-[3-[2-(2-hydroxypropylamino)pyrimidin-4-yl]-2-naphthalen-2-ylimidazol-4-yl]acetonitrile Chemical compound OC(CNC1=NC=CC(=N1)N1C(=NC=C1CC#N)C1=CC2=CC=CC=C2C=C1)C DILISPNYIVRDBP-UHFFFAOYSA-N 0.000 description 1
• OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
• 206010000021 21-hydroxylase deficiency Diseases 0.000 description 1
• 108700020831 3-Hydroxyacyl-CoA Dehydrogenase Proteins 0.000 description 1
• 101150059573 AGTR1 gene Proteins 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 102100032123 AMP deaminase 1 Human genes 0.000 description 1
• 241000224422 Acanthamoeba Species 0.000 description 1
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
• 241000186361 Actinobacteria <class> Species 0.000 description 1
• 241000607528 Aeromonas hydrophila Species 0.000 description 1
• 241000120516 African horse sickness virus Species 0.000 description 1
• 241000701386 African swine fever virus Species 0.000 description 1
• 208000000363 Agenesis of Corpus Callosum Diseases 0.000 description 1
• 241001222053 Akabane virus Species 0.000 description 1
• 208000028060 Albright disease Diseases 0.000 description 1
• 241001492267 Alcelaphine gammaherpesvirus 1 Species 0.000 description 1
• 239000012099 Alexa Fluor family Substances 0.000 description 1
• 102100035028 Alpha-L-iduronidase Human genes 0.000 description 1
• 208000033337 Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3 Diseases 0.000 description 1
• 241000004176 Alphacoronavirus Species 0.000 description 1
• 241000544678 Anisakis sp. Species 0.000 description 1
• 102100029470 Apolipoprotein E Human genes 0.000 description 1
• 101710095339 Apolipoprotein E Proteins 0.000 description 1
• 241000244185 Ascaris lumbricoides Species 0.000 description 1
• 206010068220 Aspartylglucosaminuria Diseases 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 206010003594 Ataxia telangiectasia Diseases 0.000 description 1
• 208000001827 Ataxia with vitamin E deficiency Diseases 0.000 description 1
• 208000031212 Autoimmune polyendocrinopathy Diseases 0.000 description 1
• 208000034320 Autosomal recessive spastic ataxia of Charlevoix-Saguenay Diseases 0.000 description 1
• 241000711404 Avian avulavirus 1 Species 0.000 description 1
• 102000036365 BRCA1 Human genes 0.000 description 1
• 108700020463 BRCA1 Proteins 0.000 description 1
• 101150072950 BRCA1 gene Proteins 0.000 description 1
• 241000193738 Bacillus anthracis Species 0.000 description 1
• 241000193755 Bacillus cereus Species 0.000 description 1
• 244000063299 Bacillus subtilis Species 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 201000001321 Bardet-Biedl syndrome Diseases 0.000 description 1
• 208000037663 Best vitelliform macular dystrophy Diseases 0.000 description 1
• 208000034067 Beta-sarcoglycan-related limb-girdle muscular dystrophy R4 Diseases 0.000 description 1
• 241001323415 Bhanja virus Species 0.000 description 1
• 208000033258 Bifunctional enzyme deficiency Diseases 0.000 description 1
• 241000228405 Blastomyces dermatitidis Species 0.000 description 1
• 208000009766 Blau syndrome Diseases 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 208000005692 Bloom Syndrome Diseases 0.000 description 1
• 241000120506 Bluetongue virus Species 0.000 description 1
• 108030001720 Bontoxilysin Proteins 0.000 description 1
• 241000589567 Brucella abortus Species 0.000 description 1
• 241001148106 Brucella melitensis Species 0.000 description 1
• 241001148111 Brucella suis Species 0.000 description 1
• 241001137864 Camelpox virus Species 0.000 description 1
• 241000589875 Campylobacter jejuni Species 0.000 description 1
• 208000022526 Canavan disease Diseases 0.000 description 1
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
• 239000004215 Carbon black (E152) Substances 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 208000031229 Cardiomyopathies Diseases 0.000 description 1
• 108700005857 Carnitine palmitoyl transferase 1A deficiency Proteins 0.000 description 1
• 208000005359 Carnitine palmitoyl transferase 1A deficiency Diseases 0.000 description 1
• 108700005858 Carnitine palmitoyl transferase 2 deficiency Proteins 0.000 description 1
• 201000002929 Carnitine palmitoyltransferase II deficiency Diseases 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 208000004918 Cartilage-hair hypoplasia Diseases 0.000 description 1
• 206010007747 Cataract congenital Diseases 0.000 description 1
• 208000031464 Cavernous Central Nervous System Hemangioma Diseases 0.000 description 1
• ZEOWTGPWHLSLOG-UHFFFAOYSA-N Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Chemical compound Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F ZEOWTGPWHLSLOG-UHFFFAOYSA-N 0.000 description 1
• 208000032929 Cerebral haemangioma Diseases 0.000 description 1
• 206010050337 Cerumen impaction Diseases 0.000 description 1
• 241000283153 Cetacea Species 0.000 description 1
• 201000003679 Charlevoix-Saguenay spastic ataxia Diseases 0.000 description 1
• 241001502567 Chikungunya virus Species 0.000 description 1
• 241001647378 Chlamydia psittaci Species 0.000 description 1
• 102100029172 Choline-phosphate cytidylyltransferase A Human genes 0.000 description 1
• 101710100763 Choline-phosphate cytidylyltransferase A Proteins 0.000 description 1
• 206010008723 Chondrodystrophy Diseases 0.000 description 1
• 208000033810 Choroidal dystrophy Diseases 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• 241000588923 Citrobacter Species 0.000 description 1
• 241000207199 Citrus Species 0.000 description 1
• 208000013147 Classic homocystinuria Diseases 0.000 description 1
• 241000710777 Classical swine fever virus Species 0.000 description 1
• 241000193403 Clostridium Species 0.000 description 1
• 241000193468 Clostridium perfringens Species 0.000 description 1
• 208000008020 Cohen syndrome Diseases 0.000 description 1
• 208000006992 Color Vision Defects Diseases 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 206010010356 Congenital anomaly Diseases 0.000 description 1
• 206010053138 Congenital aplastic anaemia Diseases 0.000 description 1
• 208000021599 Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type Diseases 0.000 description 1
• 208000029767 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Diseases 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 206010011224 Cough Diseases 0.000 description 1
• 241000606678 Coxiella burnetii Species 0.000 description 1
• 241000150230 Crimean-Congo hemorrhagic fever orthonairovirus Species 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• 201000007336 Cryptococcosis Diseases 0.000 description 1
• 241000221204 Cryptococcus neoformans Species 0.000 description 1
• 241000223936 Cryptosporidium parvum Species 0.000 description 1
• 241000016605 Cyclospora cayetanensis Species 0.000 description 1
• 206010071093 Cystathionine beta-synthase deficiency Diseases 0.000 description 1
• 206010011777 Cystinosis Diseases 0.000 description 1
• 102100036279 DNA (cytosine-5)-methyltransferase 1 Human genes 0.000 description 1
• 102000003844 DNA helicases Human genes 0.000 description 1
• 108090000133 DNA helicases Proteins 0.000 description 1
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
• 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
• 241000408659 Darpa Species 0.000 description 1
• 241000710829 Dengue virus group Species 0.000 description 1
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 201000010385 Dihydropyrimidine Dehydrogenase Deficiency Diseases 0.000 description 1
• 241001137876 Diphyllobothrium Species 0.000 description 1
• 241000149824 Dugbe orthonairovirus Species 0.000 description 1
• 206010066054 Dysmorphism Diseases 0.000 description 1
• 208000014094 Dystonic disease Diseases 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 241000710945 Eastern equine encephalitis virus Species 0.000 description 1
• 241001115402 Ebolavirus Species 0.000 description 1
• 241000605314 Ehrlichia Species 0.000 description 1
• 241000605310 Ehrlichia chaffeensis Species 0.000 description 1
• 241000606675 Ehrlichia ruminantium Species 0.000 description 1
• 241000224432 Entamoeba histolytica Species 0.000 description 1
• 241000588914 Enterobacter Species 0.000 description 1
• 241000991587 Enterovirus C Species 0.000 description 1
• 206010014989 Epidermolysis bullosa Diseases 0.000 description 1
• 239000004593 Epoxy Substances 0.000 description 1
• 241000408674 Eretis Species 0.000 description 1
• 241001646719 Escherichia coli O157:H7 Species 0.000 description 1
• 241000690783 Eustrongylides Species 0.000 description 1
• 108060002716 Exonuclease Proteins 0.000 description 1
• 208000033534 FKRP-related limb-girdle muscular dystrophy R9 Diseases 0.000 description 1
• 108010014172 Factor V Proteins 0.000 description 1
• 201000007371 Factor XIII Deficiency Diseases 0.000 description 1
• 206010016207 Familial Mediterranean fever Diseases 0.000 description 1
• 201000006107 Familial adenomatous polyposis Diseases 0.000 description 1
• 208000001730 Familial dysautonomia Diseases 0.000 description 1
• 201000004939 Fanconi anemia Diseases 0.000 description 1
• 102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 1
• 101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 1
• 241000190598 Flexal mammarenavirus Species 0.000 description 1
• YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
• 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
• 241000589602 Francisella tularensis Species 0.000 description 1
• 201000011240 Frontotemporal dementia Diseases 0.000 description 1
• 206010072104 Fructose intolerance Diseases 0.000 description 1
• 208000006517 Fumaric aciduria Diseases 0.000 description 1
• 108700036912 Fumaric aciduria Proteins 0.000 description 1
• 208000025499 G6PD deficiency Diseases 0.000 description 1
• 108091092584 GDNA Proteins 0.000 description 1
• 208000013381 GRACILE syndrome Diseases 0.000 description 1
• 208000027472 Galactosemias Diseases 0.000 description 1
• 208000015872 Gaucher disease Diseases 0.000 description 1
• 241000713109 Germiston virus Species 0.000 description 1
• 241000224467 Giardia intestinalis Species 0.000 description 1
• 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 1
• 206010018444 Glucose-6-phosphate dehydrogenase deficiency Diseases 0.000 description 1
• 108700006770 Glutaric Acidemia I Proteins 0.000 description 1
• 208000021097 Glutaryl-CoA dehydrogenase deficiency Diseases 0.000 description 1
• 108010068370 Glutens Proteins 0.000 description 1
• 244000068988 Glycine max Species 0.000 description 1
• 235000010469 Glycine max Nutrition 0.000 description 1
• 102100029492 Glycogen phosphorylase, muscle form Human genes 0.000 description 1
• 208000011476 Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib Diseases 0.000 description 1
• 208000032000 Glycogen storage disease due to muscle glycogen phosphorylase deficiency Diseases 0.000 description 1
• 206010018462 Glycogen storage disease type V Diseases 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 241001112691 Goatpox virus Species 0.000 description 1
• 241000711549 Hepacivirus C Species 0.000 description 1
• 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
• 208000032087 Hereditary Leber Optic Atrophy Diseases 0.000 description 1
• 208000033640 Hereditary breast cancer Diseases 0.000 description 1
• 208000028572 Hereditary chronic pancreatitis Diseases 0.000 description 1
• 206010019878 Hereditary fructose intolerance Diseases 0.000 description 1
• 208000033981 Hereditary haemochromatosis Diseases 0.000 description 1
• 206010056976 Hereditary pancreatitis Diseases 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 102000016871 Hexosaminidase A Human genes 0.000 description 1
• 108010053317 Hexosaminidase A Proteins 0.000 description 1
• 241000228404 Histoplasma capsulatum Species 0.000 description 1
• 102100031159 Homeobox protein prophet of Pit-1 Human genes 0.000 description 1
• 101000775844 Homo sapiens AMP deaminase 1 Proteins 0.000 description 1
• 101001019502 Homo sapiens Alpha-L-iduronidase Proteins 0.000 description 1
• 101000700475 Homo sapiens Glycogen phosphorylase, muscle form Proteins 0.000 description 1
• 101000706471 Homo sapiens Homeobox protein prophet of Pit-1 Proteins 0.000 description 1
• 101001083553 Homo sapiens Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial Proteins 0.000 description 1
• 101000587058 Homo sapiens Methylenetetrahydrofolate reductase Proteins 0.000 description 1
• 101001028702 Homo sapiens Mitochondrial-derived peptide MOTS-c Proteins 0.000 description 1
• 101000641122 Homo sapiens Sacsin Proteins 0.000 description 1
• 206010020429 Human ehrlichiosis Diseases 0.000 description 1
• 102100030358 Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial Human genes 0.000 description 1
• 208000007599 Hyperkalemic periodic paralysis Diseases 0.000 description 1
• 208000000563 Hyperlipoproteinemia Type II Diseases 0.000 description 1
• 208000034600 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome Diseases 0.000 description 1
• 206010049933 Hypophosphatasia Diseases 0.000 description 1
• 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
• 244000017020 Ipomoea batatas Species 0.000 description 1
• 235000002678 Ipomoea batatas Nutrition 0.000 description 1
• 208000000420 Isovaleric acidemia Diseases 0.000 description 1
• 241000531220 Issyk-Kul virus Species 0.000 description 1
• 241000710842 Japanese encephalitis virus Species 0.000 description 1
• 241000588748 Klebsiella Species 0.000 description 1
• 241000178324 Koutango virus Species 0.000 description 1
• 208000028226 Krabbe disease Diseases 0.000 description 1
• 208000003140 Kyasanur forest disease Diseases 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• 206010023927 Lassa fever Diseases 0.000 description 1
• 206010056715 Laurence-Moon-Bardet-Biedl syndrome Diseases 0.000 description 1
• 201000000639 Leber hereditary optic neuropathy Diseases 0.000 description 1
• 241000589248 Legionella Species 0.000 description 1
• 208000007764 Legionnaires' Disease Diseases 0.000 description 1
• 241000533950 Leucojum Species 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 241000186779 Listeria monocytogenes Species 0.000 description 1
• 241000710769 Louping ill virus Species 0.000 description 1
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
• 241000609846 Lumpy skin disease virus Species 0.000 description 1
• 241000712899 Lymphocytic choriomeningitis mammarenavirus Species 0.000 description 1
• 208000035177 MELAS Diseases 0.000 description 1
• 208000035172 MERRF Diseases 0.000 description 1
• 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
• 240000003183 Manihot esculenta Species 0.000 description 1
• 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 241000608292 Mayaro virus Species 0.000 description 1
• 201000001853 McCune-Albright syndrome Diseases 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 108700000232 Medium chain acyl CoA dehydrogenase deficiency Proteins 0.000 description 1
• 206010072654 Medium-chain acyl-coenzyme A dehydrogenase deficiency Diseases 0.000 description 1
• 241001643857 Menangle virus Species 0.000 description 1
• 201000011442 Metachromatic leukodystrophy Diseases 0.000 description 1
• 102100029684 Methylenetetrahydrofolate reductase Human genes 0.000 description 1
• 208000000570 Methylenetetrahydrofolate reductase deficiency Diseases 0.000 description 1
• 108700019352 Methylenetetrahydrofolate reductase deficiency Proteins 0.000 description 1
• 208000035155 Mitochondrial DNA-associated Leigh syndrome Diseases 0.000 description 1
• 102100027891 Mitochondrial chaperone BCS1 Human genes 0.000 description 1
• 102100037173 Mitochondrial-derived peptide MOTS-c Human genes 0.000 description 1
• 241000700627 Monkeypox virus Species 0.000 description 1
• 241000868135 Mucambo virus Species 0.000 description 1
• 208000008955 Mucolipidoses Diseases 0.000 description 1
• 206010056886 Mucopolysaccharidosis I Diseases 0.000 description 1
• 208000028781 Mucopolysaccharidosis type 1 Diseases 0.000 description 1
• 208000007326 Muenke Syndrome Diseases 0.000 description 1
• 206010073149 Multiple endocrine neoplasia Type 2 Diseases 0.000 description 1
• 206010073148 Multiple endocrine neoplasia type 2A Diseases 0.000 description 1
• 241000710908 Murray Valley encephalitis virus Species 0.000 description 1
• 201000005805 Murray valley encephalitis Diseases 0.000 description 1
• 235000003805 Musa ABB Group Nutrition 0.000 description 1
• 241000186366 Mycobacterium bovis Species 0.000 description 1
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
• 241000204031 Mycoplasma Species 0.000 description 1
• 241000204025 Mycoplasma capricolum Species 0.000 description 1
• 241000202936 Mycoplasma mycoides Species 0.000 description 1
• 208000012905 Myotonic disease Diseases 0.000 description 1
• 241000863434 Myxococcales Species 0.000 description 1
• GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 1
• HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 1
• 241001501625 Nanophyetus Species 0.000 description 1
• 208000034965 Nemaline Myopathies Diseases 0.000 description 1
• 206010029164 Nephrotic syndrome Diseases 0.000 description 1
• 208000004485 Nijmegen breakage syndrome Diseases 0.000 description 1
• 241000526636 Nipah henipavirus Species 0.000 description 1
• 241000714209 Norwalk virus Species 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• TTZMPOZCBFTTPR-UHFFFAOYSA-N O=P1OCO1 Chemical compound O=P1OCO1 TTZMPOZCBFTTPR-UHFFFAOYSA-N 0.000 description 1
• 208000011448 Omsk hemorrhagic fever Diseases 0.000 description 1
• 241000283283 Orcinus orca Species 0.000 description 1
• 241000250439 Oropouche virus Species 0.000 description 1
• 241000150452 Orthohantavirus Species 0.000 description 1
• 241000120522 Orungo virus Species 0.000 description 1
• 208000004286 Osteochondrodysplasias Diseases 0.000 description 1
• 201000011392 Pallister-Hall syndrome Diseases 0.000 description 1
• 102000005327 Palmitoyl protein thioesterase Human genes 0.000 description 1
• 108020002591 Palmitoyl protein thioesterase Proteins 0.000 description 1
• 206010033892 Paraplegia Diseases 0.000 description 1
• 208000004843 Pendred Syndrome Diseases 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 241000760727 Peronosclerospora philippinensis Species 0.000 description 1
• 102000009125 Peroxisomal Bifunctional Enzyme Human genes 0.000 description 1
• 208000012202 Pervasive developmental disease Diseases 0.000 description 1
• 241000682645 Phakopsora pachyrhizi Species 0.000 description 1
• 201000011252 Phenylketonuria Diseases 0.000 description 1
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
• 241000425347 Phyla <beetle> Species 0.000 description 1
• 241000711965 Piry virus Species 0.000 description 1
• 241000013557 Plantaginaceae Species 0.000 description 1
• 235000015266 Plantago major Nutrition 0.000 description 1
• 108010077971 Plasminogen Inactivators Proteins 0.000 description 1
• 102000010752 Plasminogen Inactivators Human genes 0.000 description 1
• 241000606999 Plesiomonas shigelloides Species 0.000 description 1
• 241000723784 Plum pox virus Species 0.000 description 1
• 239000004952 Polyamide Substances 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 241000710884 Powassan virus Species 0.000 description 1
• 206010036790 Productive cough Diseases 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 241000588769 Proteus <enterobacteria> Species 0.000 description 1
• 108010094028 Prothrombin Proteins 0.000 description 1
• 102100027378 Prothrombin Human genes 0.000 description 1
• 241000588768 Providencia Species 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
• 241000589771 Ralstonia solanacearum Species 0.000 description 1
• 101100240886 Rattus norvegicus Nptx2 gene Proteins 0.000 description 1
• 206010057190 Respiratory tract infections Diseases 0.000 description 1
• 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
• 208000006289 Rett Syndrome Diseases 0.000 description 1
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
• 201000008539 Rhizomelic chondrodysplasia punctata type 1 Diseases 0.000 description 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
• 241000606697 Rickettsia prowazekii Species 0.000 description 1
• 241000606695 Rickettsia rickettsii Species 0.000 description 1
• 241000713124 Rift Valley fever virus Species 0.000 description 1
• 201000001638 Riley-Day syndrome Diseases 0.000 description 1
• 241000711897 Rinderpest morbillivirus Species 0.000 description 1
• 241000702670 Rotavirus Species 0.000 description 1
• CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 102100034272 Sacsin Human genes 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
• 241000710961 Semliki Forest virus Species 0.000 description 1
• 241000607720 Serratia Species 0.000 description 1
• 241000700665 Sheeppox virus Species 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• 108700017825 Short chain Acyl CoA dehydrogenase deficiency Proteins 0.000 description 1
• 201000004283 Shwachman-Diamond syndrome Diseases 0.000 description 1
• 108010016797 Sickle Hemoglobin Proteins 0.000 description 1
• 208000018020 Sickle cell-beta-thalassemia disease syndrome Diseases 0.000 description 1
• 206010048676 Sjogren-Larsson Syndrome Diseases 0.000 description 1
• 241001428894 Small ruminant morbillivirus Species 0.000 description 1
• 208000001203 Smallpox Diseases 0.000 description 1
• 201000007410 Smith-Lemli-Opitz syndrome Diseases 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
• 229920002125 Sokalan® Polymers 0.000 description 1
• 240000006394 Sorghum bicolor Species 0.000 description 1
• 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
• 208000032930 Spastic paraplegia Diseases 0.000 description 1
• 241000907333 Spondweni virus Species 0.000 description 1
• 241001149963 Sporothrix schenckii Species 0.000 description 1
• 101100461456 Staphylococcus aureus nuc gene Proteins 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• 238000000692 Student's t-test Methods 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 241000709710 Swine vesicular disease virus Species 0.000 description 1
• 241000827175 Synchytrium endobioticum Species 0.000 description 1
• 239000008051 TBE buffer Substances 0.000 description 1
• 239000004809 Teflon Substances 0.000 description 1
• 229920006362 Teflon® Polymers 0.000 description 1
• 229910052771 Terbium Inorganic materials 0.000 description 1
• QHNORJFCVHUPNH-UHFFFAOYSA-L To-Pro-3 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 QHNORJFCVHUPNH-UHFFFAOYSA-L 0.000 description 1
• 241000223997 Toxoplasma gondii Species 0.000 description 1
• 241000243774 Trichinella Species 0.000 description 1
• 241001489145 Trichuris trichiura Species 0.000 description 1
• 108700036262 Trifunctional Protein Deficiency With Myopathy And Neuropathy Proteins 0.000 description 1
• 108010039203 Tripeptidyl-Peptidase 1 Proteins 0.000 description 1
• 102100034197 Tripeptidyl-peptidase 1 Human genes 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 208000007824 Type A Niemann-Pick Disease Diseases 0.000 description 1
• 206010045261 Type IIa hyperlipidaemia Diseases 0.000 description 1
• 208000032001 Tyrosinemia type 1 Diseases 0.000 description 1
• 229920001646 UPILEX Polymers 0.000 description 1
• 241000726423 Variola major virus Species 0.000 description 1
• 241000519618 Variola minor virus Species 0.000 description 1
• 241000700647 Variola virus Species 0.000 description 1
• 241000710959 Venezuelan equine encephalitis virus Species 0.000 description 1
• 241000711975 Vesicular stomatitis virus Species 0.000 description 1
• 241000607598 Vibrio Species 0.000 description 1
• 241000602423 Vibrio cholerae O1 Species 0.000 description 1
• 241000936820 Vibrio cholerae non-O1 Species 0.000 description 1
• 206010047400 Vibrio infections Diseases 0.000 description 1
• 241000607272 Vibrio parahaemolyticus Species 0.000 description 1
• 241000607265 Vibrio vulnificus Species 0.000 description 1
• 201000006793 Walker-Warburg syndrome Diseases 0.000 description 1
• 241000710886 West Nile virus Species 0.000 description 1
• 208000018839 Wilson disease Diseases 0.000 description 1
• 201000001408 X-linked juvenile retinoschisis 1 Diseases 0.000 description 1
• 208000017441 X-linked retinoschisis Diseases 0.000 description 1
• 241000589652 Xanthomonas oryzae Species 0.000 description 1
• 241000204362 Xylella fastidiosa Species 0.000 description 1
• 241000710772 Yellow fever virus Species 0.000 description 1
• 241000607447 Yersinia enterocolitica Species 0.000 description 1
• 241000607479 Yersinia pestis Species 0.000 description 1
• 241000607477 Yersinia pseudotuberculosis Species 0.000 description 1
• ULHRKLSNHXXJLO-UHFFFAOYSA-L Yo-Pro-1 Chemical compound [I-].[I-].C1=CC=C2C(C=C3N(C4=CC=CC=C4O3)C)=CC=[N+](CCC[N+](C)(C)C)C2=C1 ULHRKLSNHXXJLO-UHFFFAOYSA-L 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
• 201000004525 Zellweger Syndrome Diseases 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 230000001133 acceleration Effects 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 208000008919 achondroplasia Diseases 0.000 description 1
• 201000000761 achromatopsia Diseases 0.000 description 1
• 238000003916 acid precipitation Methods 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 239000000999 acridine dye Substances 0.000 description 1
• 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
• 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 206010001689 alkaptonuria Diseases 0.000 description 1
• 239000013566 allergen Substances 0.000 description 1
• 208000006682 alpha 1-Antitrypsin Deficiency Diseases 0.000 description 1
• 201000006288 alpha thalassemia Diseases 0.000 description 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
• 201000008333 alpha-mannosidosis Diseases 0.000 description 1
• 150000001413 amino acids Chemical class 0.000 description 1
• 230000003466 anti-cipated effect Effects 0.000 description 1
• 229940045686 antimetabolites antineoplastic purine analogs Drugs 0.000 description 1
• 229940045688 antineoplastic antimetabolites pyrimidine analogues Drugs 0.000 description 1
• 210000001742 aqueous humor Anatomy 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 201000003554 argininosuccinic aciduria Diseases 0.000 description 1
• 238000003491 array Methods 0.000 description 1
• 238000003149 assay kit Methods 0.000 description 1
• 230000000712 assembly Effects 0.000 description 1
• 238000000429 assembly Methods 0.000 description 1
• 208000029560 autism spectrum disease Diseases 0.000 description 1
• 201000009561 autosomal recessive limb-girdle muscular dystrophy type 2D Diseases 0.000 description 1
• 201000009553 autosomal recessive limb-girdle muscular dystrophy type 2E Diseases 0.000 description 1
• 201000009510 autosomal recessive limb-girdle muscular dystrophy type 2I Diseases 0.000 description 1
• 229940065181 bacillus anthracis Drugs 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 208000005980 beta thalassemia Diseases 0.000 description 1
• SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
• 210000000941 bile Anatomy 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 239000012472 biological sample Substances 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 206010071434 biotinidase deficiency Diseases 0.000 description 1
• 230000036760 body temperature Effects 0.000 description 1
• 238000009835 boiling Methods 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 231100001103 botulinum neurotoxin Toxicity 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 229940056450 brucella abortus Drugs 0.000 description 1
• 229940038698 brucella melitensis Drugs 0.000 description 1
• 239000008366 buffered solution Substances 0.000 description 1
• 229940074375 burkholderia mallei Drugs 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 229940095731 candida albicans Drugs 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 201000004010 carnitine palmitoyltransferase I deficiency Diseases 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 239000000919 ceramic Substances 0.000 description 1
• 229910010293 ceramic material Inorganic materials 0.000 description 1
• 201000000760 cerebral cavernous malformation Diseases 0.000 description 1
• 230000003196 chaotropic effect Effects 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 239000013626 chemical specie Substances 0.000 description 1
• 230000000973 chemotherapeutic effect Effects 0.000 description 1
• 208000003571 choroideremia Diseases 0.000 description 1
• 238000011208 chromatographic data Methods 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 210000001268 chyle Anatomy 0.000 description 1
• 210000004913 chyme Anatomy 0.000 description 1
• 230000008632 circadian clock Effects 0.000 description 1
• 235000020971 citrus fruits Nutrition 0.000 description 1
• 208000029664 classic familial adenomatous polyposis Diseases 0.000 description 1
• 239000004927 clay Substances 0.000 description 1
• 201000007254 color blindness Diseases 0.000 description 1
• 239000002361 compost Substances 0.000 description 1
• 150000001875 compounds Chemical class 0.000 description 1
• 238000000748 compression moulding Methods 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 235000008504 concentrate Nutrition 0.000 description 1
• 239000004020 conductor Substances 0.000 description 1
• 208000030483 congenital disorder of glycosylation Ib Diseases 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 239000002872 contrast media Substances 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 238000013479 data entry Methods 0.000 description 1
• 238000013523 data management Methods 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 238000000708 deep reactive-ion etching Methods 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 238000000151 deposition Methods 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000002059 diagnostic imaging Methods 0.000 description 1
• 150000004985 diamines Chemical class 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 1
• 235000004879 dioscorea Nutrition 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
• KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 239000002359 drug metabolite Substances 0.000 description 1
• 238000002651 drug therapy Methods 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 208000010118 dystonia Diseases 0.000 description 1
• 208000016570 early-onset generalized limb-onset dystonia Diseases 0.000 description 1
• 208000002169 ectodermal dysplasia Diseases 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 229940007078 entamoeba histolytica Drugs 0.000 description 1
• 239000002702 enteric coating Substances 0.000 description 1
• 239000003344 environmental pollutant Substances 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 229930013356 epothilone Natural products 0.000 description 1
• 150000003883 epothilone derivatives Chemical class 0.000 description 1
• 238000011066 ex-situ storage Methods 0.000 description 1
• 102000013165 exonuclease Human genes 0.000 description 1
• 210000001808 exosome Anatomy 0.000 description 1
• 238000010195 expression analysis Methods 0.000 description 1
• 210000003722 extracellular fluid Anatomy 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 208000014337 facial nerve disease Diseases 0.000 description 1
• 108010091897 factor V Leiden Proteins 0.000 description 1
• 201000007219 factor XI deficiency Diseases 0.000 description 1
• 201000001386 familial hypercholesterolemia Diseases 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 238000001917 fluorescence detection Methods 0.000 description 1
• 238000001215 fluorescent labelling Methods 0.000 description 1
• 239000011737 fluorine Substances 0.000 description 1
• 229910052731 fluorine Inorganic materials 0.000 description 1
• 229940118764 francisella tularensis Drugs 0.000 description 1
• 208000014346 fumarase deficiency Diseases 0.000 description 1
• 238000007306 functionalization reaction Methods 0.000 description 1
• 244000037671 genetically modified crops Species 0.000 description 1
• 235000003869 genetically modified organism Nutrition 0.000 description 1
• 238000003205 genotyping method Methods 0.000 description 1
• 229940085435 giardia lamblia Drugs 0.000 description 1
• 208000008605 glucosephosphate dehydrogenase deficiency Diseases 0.000 description 1
• 235000021312 gluten Nutrition 0.000 description 1
• 208000005516 glycogen storage disease Ib Diseases 0.000 description 1
• 201000004534 glycogen storage disease V Diseases 0.000 description 1
• 208000011460 glycogen storage disease due to glucose-6-phosphatase deficiency type IA Diseases 0.000 description 1
• 230000005484 gravity Effects 0.000 description 1
• 230000037308 hair color Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 201000000391 hemochromatosis type 1 Diseases 0.000 description 1
• 208000025581 hereditary breast carcinoma Diseases 0.000 description 1
• 125000005842 heteroatom Chemical group 0.000 description 1
• 125000000623 heterocyclic group Chemical group 0.000 description 1
• 208000013144 homocystinuria due to methylene tetrahydrofolate reductase deficiency Diseases 0.000 description 1
• 229920001519 homopolymer Polymers 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 235000020256 human milk Nutrition 0.000 description 1
• 210000004251 human milk Anatomy 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• 150000002430 hydrocarbons Chemical class 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 201000008980 hyperinsulinism Diseases 0.000 description 1
• 201000010072 hypochondroplasia Diseases 0.000 description 1
• 208000006278 hypochromic anemia Diseases 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 229940097275 indigo Drugs 0.000 description 1
• COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 238000002329 infrared spectrum Methods 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 238000001746 injection moulding Methods 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 210000002977 intracellular fluid Anatomy 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
• 230000001788 irregular Effects 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 208000006443 lactic acidosis Diseases 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 239000010871 livestock manure Substances 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 238000005461 lubrication Methods 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 238000003754 machining Methods 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
• 239000000347 magnesium hydroxide Substances 0.000 description 1
• 235000012254 magnesium hydroxide Nutrition 0.000 description 1
• 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 235000009973 maize Nutrition 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 238000004519 manufacturing process Methods 0.000 description 1
• 230000008774 maternal effect Effects 0.000 description 1
• 238000010339 medical test Methods 0.000 description 1
• 208000005548 medium chain acyl-CoA dehydrogenase deficiency Diseases 0.000 description 1
• 208000002839 megalencephalic leukoencephalopathy with subcortical cysts Diseases 0.000 description 1
• 210000004914 menses Anatomy 0.000 description 1
• QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
• 229910052753 mercury Inorganic materials 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 239000002905 metal composite material Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
• 239000000693 micelle Substances 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 230000002438 mitochondrial effect Effects 0.000 description 1
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
• 239000002324 mouth wash Substances 0.000 description 1
• 229940051866 mouthwash Drugs 0.000 description 1
• 210000003097 mucus Anatomy 0.000 description 1
• 238000003541 multi-stage reaction Methods 0.000 description 1
• 208000011042 muscle-eye-brain disease Diseases 0.000 description 1
• 239000002105 nanoparticle Substances 0.000 description 1
• 208000009928 nephrosis Diseases 0.000 description 1
• 231100001027 nephrosis Toxicity 0.000 description 1
• 230000000926 neurological effect Effects 0.000 description 1
• 201000007657 neuronal ceroid lipofuscinosis 5 Diseases 0.000 description 1
• 230000007827 neuronopathy Effects 0.000 description 1
• 230000007823 neuropathy Effects 0.000 description 1
• 125000004433 nitrogen atom Chemical group N* 0.000 description 1
• 101150100619 nuc gene Proteins 0.000 description 1
• 210000000633 nuclear envelope Anatomy 0.000 description 1
• 238000001821 nucleic acid purification Methods 0.000 description 1
• 230000000269 nucleophilic effect Effects 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 125000003835 nucleoside group Chemical group 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 229920000620 organic polymer Polymers 0.000 description 1
• 239000001014 oxazin dye Substances 0.000 description 1
• 208000027838 paramyotonia congenita of Von Eulenburg Diseases 0.000 description 1
• 230000003071 parasitic effect Effects 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 238000010647 peptide synthesis reaction Methods 0.000 description 1
• 239000008177 pharmaceutical agent Substances 0.000 description 1
• 239000012782 phase change material Substances 0.000 description 1
• 150000004713 phosphodiesters Chemical class 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• 208000024335 physical disease Diseases 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 238000009832 plasma treatment Methods 0.000 description 1
• 239000002797 plasminogen activator inhibitor Substances 0.000 description 1
• 210000004910 pleural fluid Anatomy 0.000 description 1
• 238000005498 polishing Methods 0.000 description 1
• 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
• 229920000058 polyacrylate Polymers 0.000 description 1
• 229920002647 polyamide Polymers 0.000 description 1
• 208000030761 polycystic kidney disease Diseases 0.000 description 1
• 229920000728 polyester Polymers 0.000 description 1
• 229920000570 polyether Polymers 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 239000004926 polymethyl methacrylate Substances 0.000 description 1
• 229920000098 polyolefin Polymers 0.000 description 1
• 208000001061 polyostotic fibrous dysplasia Diseases 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 229920001184 polypeptide Polymers 0.000 description 1
• 208000015768 polyposis Diseases 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
• 239000004810 polytetrafluoroethylene Substances 0.000 description 1
• 229920002635 polyurethane Polymers 0.000 description 1
• 239000004814 polyurethane Substances 0.000 description 1
• 235000012015 potatoes Nutrition 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 229940002612 prodrug Drugs 0.000 description 1
• 239000000651 prodrug Substances 0.000 description 1
• 239000003531 protein hydrolysate Substances 0.000 description 1
• 229940039716 prothrombin Drugs 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• 210000004915 pus Anatomy 0.000 description 1
• 201000010108 pycnodysostosis Diseases 0.000 description 1
• 150000003230 pyrimidines Chemical class 0.000 description 1
• 125000000714 pyrimidinyl group Chemical group 0.000 description 1
• 238000004451 qualitative analysis Methods 0.000 description 1
• 208000022563 qualitative or quantitative defects of alpha-sarcoglycan Diseases 0.000 description 1
• 208000022561 qualitative or quantitative defects of beta-sarcoglycan Diseases 0.000 description 1
• 238000001959 radiotherapy Methods 0.000 description 1
• 239000000376 reactant Substances 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 238000002271 resection Methods 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 201000007714 retinoschisis Diseases 0.000 description 1
• 239000001022 rhodamine dye Substances 0.000 description 1
• 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
• 208000007442 rickets Diseases 0.000 description 1
• 229940046939 rickettsia prowazekii Drugs 0.000 description 1
• 229940075118 rickettsia rickettsii Drugs 0.000 description 1
• 238000012776 robust process Methods 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 208000010532 sarcoglycanopathy Diseases 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 238000007789 sealing Methods 0.000 description 1
• 210000002374 sebum Anatomy 0.000 description 1
• 229910052711 selenium Inorganic materials 0.000 description 1
• 239000011669 selenium Substances 0.000 description 1
• 210000000582 semen Anatomy 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 208000001392 short chain acyl-CoA dehydrogenase deficiency Diseases 0.000 description 1
• SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
• 229920005573 silicon-containing polymer Polymers 0.000 description 1
• 238000004557 single molecule detection Methods 0.000 description 1
• 108700014590 single-stranded DNA binding proteins Proteins 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 238000002174 soft lithography Methods 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 210000003802 sputum Anatomy 0.000 description 1
• 208000024794 sputum Diseases 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 150000003457 sulfones Chemical class 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• 210000001179 synovial fluid Anatomy 0.000 description 1
• 238000012353 t test Methods 0.000 description 1
• 210000001138 tear Anatomy 0.000 description 1
• GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
• 201000003896 thanatophoric dysplasia Diseases 0.000 description 1
• 150000003568 thioethers Chemical class 0.000 description 1
• ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 239000012780 transparent material Substances 0.000 description 1
• 238000012384 transportation and delivery Methods 0.000 description 1
• 201000007905 transthyretin amyloidosis Diseases 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 201000011296 tyrosinemia Diseases 0.000 description 1
• 201000007972 tyrosinemia type I Diseases 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• 201000000627 variola minor Diseases 0.000 description 1
• 208000014016 variola minor infection Diseases 0.000 description 1
• 201000007790 vitelliform macular dystrophy Diseases 0.000 description 1
• 210000004916 vomit Anatomy 0.000 description 1
• 230000008673 vomiting Effects 0.000 description 1
• 238000003631 wet chemical etching Methods 0.000 description 1
• 229940051021 yellow-fever virus Drugs 0.000 description 1
• 229940098232 yersinia enterocolitica Drugs 0.000 description 1